Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 3, 1998, Pages 581-591

  Cheng, Tong ^a,b   Cao, Wei ^a,b   Wen, Rong ^c   Steinberg, Roy H ^a,b   LaVail, Matthew M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; MESSENGER RNA; PROSTAGLANDIN E2; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; VASCULOTROPIN; CYCLIC AMP; ENDOTHELIAL CELL GROWTH FACTOR; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR 2; LYMPHOKINE; PHORBOL 13 ACETATE 12 MYRISTATE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; EYE PROTECTION; GENE EXPRESSION; INFLAMMATION; MESSENGER RNA SYNTHESIS; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; RETINA INJURY; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; NERVE CELL; NEWBORN; NORTHERN BLOTTING; RETINA; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, NORTHERN; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; LYMPHOKINES; NEURONS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031594643     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Hall ED, Yonkers PA, Taylor BM, Sun FF. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord. J Neurotrauma. 1995;12:245-256.
2. Pinson A, Halabi A, Shohami E. Mechanical injury increases eicosanoid production in cultured cardiomyocytes. Prostaglandins Leukot Essent Fatty Acids. 1992;46:9-13.
3. Preud'homme Y, Demolle D, Boeynaems JM. Metabolism of arachidonic acid in rabbit iris and retina. Invest Ophthalmol Vis Sci. 1985;26:1336-1342.
4. 2 and blood aqueous barrier disruption. Ophthalmic Res. 1990;22:253-259.
5. 2 levels. Prostaglandins. 1991;41:143-155.
6. 2 changes in the retina and optic nerve of an eye with injured optic verve. Neuroscience. 1991;45:221-225.
7. Naveh N, Belkin M, Ben-Chaim O, Weissman C, Treister G. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment. Ophthalmic Res. 1990;22:3-11.
8. Stjernschantz J. Autocoids and peptides in pharmacology of the eye. In: Sears ML, ed. Handbook of Experimental Pharmacology. Vol. 69. Berlin: Springer-Verlag; 1984:311-365.
9. Flower RW, Blake DA. Retrolental fibroplasia-evidence for a role of the prostaglandin cascade in the pathogenesis of oxygen induced retinopathy in the new born beagle. Pediatr Res. 1981;15:1293-1302.
10. Flower RW, Mcleod DS, Wajer SD, Sendi GS, Egner PG, Dubin NH. Prostaglandins as mediators of vasotonia in the immature retina. Pediatrics. 1984;73:440-444.
11. Nancy CJ, Barry M. PGE2: a mediator of corneal endothelial wound repair in vitro. Am J Physiol. 1994;266:C269-C275.
12. 2 and angiogenesis. Proc Soc Exp Med. 1983;172:214-218.
13. Benezra D. Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. Am J Ophthalmol. 1978;86: 455-461.
14. 2 protection of rat liver against acute injury by galactosamine, acetaminophen, ethanol and ANIT. Gastroenterology. 1981;80: 1349.
15. Hasanoglu E, Ulnoglu O, Ercan ZS. The protective effects of iloprost and thromboxane synthetase inhibitor, UK 38485, against glycerol-induced acute renal failure in rats. Prostaglandins Leukot Essent Fatty Acids. 1991;43:99-102.
16. 2 on diet-induced acute pancreatitis in mice. Gastroenterology. 1980;78:777-781.
17. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 1979;77:761-767.
18. Stachura J, Kaluza J. Influence of prostaglandins on actinomycin c-induced degeneration of embryonal neuroectodermal tissue. Prostaglandins. 1982;24:433-440.
19. Cazevieille C, Muller A, Meynier F, Dutrait N, Bonne C. Protection by prostaglandins from glutamate toxicity in cortical neurons. Neurochem Int. 1994;24:395-398.
20. 2 against the toxic effects of actinomycin C on embryonic neural retina cells. Prostaglandins. 1992;44:129-134.
21. 1 in osteoblasts. J Clin Invest. 1994;93: 2490-2496.
22. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
23. Eliott D, Amin RH, Frank RN, Puklin JE, Abrams GW. Vascular endothelial growth factor (VEGF) expression in retinal Müller cells and optic nerve glial cells in non-proliferative diabetic retinopathy. [ARVO Abstract.] Invest Ophthalmol Vis Sci. 1996;37:573:B485.
24. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
25. Pierce EA, Avery RL, Foley DE, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA. 1995;92:905-909.
26. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L. Supression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 1995;92: 10457-10461.
27. Kitaoka T, Morse LS, Schneeberger S, Ishigooka H, Hjelmeland LM. Expression of FGF5 in choroidal neovascular membranes associated with ARMD. Curr Eye Res. 1997;16:196-199.
28. Soubrane G, Cohen SY, Dekayre T, et al. Basic fibroblast growth factor exprimentally induced choroidal angiogenesis in the minipig. Curr Eye Res. 1994;13:183-195.
29. Wagner JA. The fibroblast growth factors: an emerging family of neural growth factors. Curr Top Microbiol Immunol. 1991;165: 95-118.
30. Baird A. Fibroblast growth factors: activities and significance of non-neurotrophin neurotrophic growth factors. Curr Opin Neurobiol. 1994;4:78-86.
31. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature. 1990;347:83-86.
32. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Basic fibroblast growth factor and local injury protect photoreceptors from light damage in the rat. J Neurosci. 1992;12:3554-3567.
33. LaVail MM, Unoki K, Yasumura D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA. 1992;89:11249-11253.
34. Wen R, Song Y, Cheng T, Matthes MT, Yasumura D, LaVail MM, Steinberg RH. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J Neurosci. 1995;15:7377-7385.
35. Cao W, Wen R, Li F, Cheng T, Steinberg RH. Induction of bFGF mRNA by bFGF in cultured rat Müller cells. Invest Ophthalmol Vis Sci. 1997;38:1358-1366.
36. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995;372:83-87.
37. Farrell ER. RNA Methodologies: A Laboratory Guide for Isolation and Characterization. San Diego: Academic; 1993:62-67.
38. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
39. Shimasaki S, Emoto N, Koba A, et al. Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem Biophys Res Commun. 1988;157:256-263.
40. Bowman LH, Rabin B, Schlessinger D. Multiple ribosomal RNA cleavage pathways in mammalian cells. Nucleic Acids Res. 1981; 9:4951-4966.
41. Harris DN, Asaad MM, Phillips MB, Goldenberg HJ, Antonaccio MJ. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. J Cyclic Nucleotide Res. 1979;5: 125-134.
42. Bruns RF, Miller FD, Merriman RL, et al. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun. 1991;176:288-293.
43. Lowe WL Jr, Yorek MA, Karpen CW, et al. Activation of protein kinase-C differentially regulates insulin-like growth factor-I and basic fibroblast growth factor messenger RNA levels. Mol Endocriol. 1992;6:741-752.
44. Stachowiak MK, Moffett J, Joy A, Puchacz E, Florkiewicz R, Stachowiak EK. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J Cell Bio. 1994;127:203-223.
45. 1 subtype. J Biol Chem. 1993;268:26767-26772.
46. 2 subtype. Mol Pharmacol. 1994;46:213-220.
47. 3 prostanoid receptor. FEBS Lett. 1994;338:170-174.
48. 2 subtype. J Biol Chem. 1994;269:11873-11877.
49. 3 receptors: evidence of three variants with differing carboxyl termini. Br J Pharmacol. 1994;112:377-385.
50. 2. Eur J Biochem. 1995;228:23-30.
51. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev. 1992;13:18-32.
52. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1995;1:1024-1028.
53. Patz A. Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol. 1982;94:715-743.
54. Flynn JT. In: Eichenbaum JW, Mamelok AE, Mittl RN, Orellana J, eds. Treatment of Retinopathy of Prematurity. Chicago: Year Book Medical Publishers; 1990:81-117.
55. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
56. Behzadian MA, Feng Y, Wang X, Plout J, Caldwell RB. Müller cells stimulate endothelial cell growth by releasing VEGF. [ARVO Abstract.] Invest Ophthalmol Vis Sci. 1996;37:3649:B435.
57. Kitano S, Hori S, Yamashita H, Yamashita T, Miura M. Vascular endothelial growth factor is induced in response to transforming growth factor-β in cultured Müller cells. [ARVO Abstract.] Invest Ophthalmol Vis Sci. 1996;37:3651:B437.
58. Bazan NG. In: Bito LZ, Stjernschantz J, eds. The Ocular Effect of Prostaglandins and Other Eiocosanoids. New York: Alan R. Liss; 1989:15-37.
59. Stachura J, Tarnawski A, Ivey KJ, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology. 1981;79:614-618.
60. 2 on the liver and kidney. Prostaglandins. 1981;21:97-99.
61. 2 on diet induced acute pancreatitis in mice. Gastroenterology. 1980;78:777-781.
62. Araki H, Lefer AM. Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol. 1980;238: H176-H179.
63. Conary JT, Parker RE, Christman BW, et al. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. J Clin Invest. 1994;93:1834-1840.